Naturex eligible for the "long-only" DSS, effective 16 February 2011 | Bourse Reflex
Accueil > Actualités > Communiqués

Naturex eligible for the "long-only" DSS, effective 16 February 2011

Mercredi 16 Fév 2011 à 18:40

Avignon, 16 February 2011 - Naturex, the global leader in speciality plant-based natural ingredients, announces that its securities will be eligible for the "long-only" DSS on NYSE Euronext Paris, starting on 16 February 2011.

 

A service making it possible to benefit from the leverage effect and from a deferred settlement
Within the framework of its programme for developing liquidity in the regulated market, NYSE Euronext Paris has updated the list of securities that have a minimum daily transaction volume of 100,000 euros, eligible for the "long-only" DSS.
The Deferred Settlement Service allows investors to benefit from the leverage effect as well as from a deferred settlement. It is as such possible to purchase securities without immediately settling the entire amount and to take maximum advantage of an expected increase; the securities are settled at the end of the trading month.
The notion of "long-only" means that these securities are eligible only for purchase, which eliminates the risk of downward speculative movements on the securities, linked to the short sale principle.

 

Enhanced attractiveness for the Naturex security
This admission to the "long-only" DSS will participate in increasing the daily volume traded and the liquidity of the Naturex security, and will consequently encourage its visibility and its attractiveness in the FINANCIAL community, in France as well as abroad.
In 2010, nearly 1,300,000 Naturex securities were traded, for a total of 46 million euros in capital.

 

 

If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.fr

 

Upcoming publications and events

  • Consolidated yearly results :31 March 2011
  • Midcap Event Frankfurt : 7 - 8 March 2011
  • Midcap Event Brussels : 31 March – 1 April 2011
  • Paris SFAF Meeting : 4 April 2011

NATUREX has been listed on segment B of NYSE Euronext Paris since October 1996

NATUREX Number of shares in the capital: 6,410,931
  • 4,959,935 ordinary shares (ISIN FR0000054694)
  • 1,450,996 preferred shares (ISIN FR0000010833251)
Naturex is part of the following indexes: SBF250, CAC All Shares, CAC Mid&Small 190, CAC Small 90, Gaïa Index
Naturex is eligible for the “long-only” DSS on NYSE Euronext Paris.

MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP

About Naturex
Naturex is the global leader in speciality plant-based natural ingredients.

The Group, organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care - produces and markets specialty plant-based natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 950 people and has high-performance industrial resources through its 11 industrial sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also benefits from sales presence around the world through a dedicated network in 16 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Australia, the United States and Brazil).

Naturex’s sound performance is linked to the fast-growing demand for natural products and its capacity to provide manufacturers with the personalised means to meet the requirements of their end consumers. The Group's strength lies in its ability to position itself on specific products which constitute niche markets, thanks to sustained Research & Development.

 

Naturex Contacts

Jacques Dikansky
Chairman and CEO
Tel.: +33 (0)4 90 23 96 89
naturex@naturex.com
Thierry Lambert
Vice-Chairman and CFO
Tel.: +33 (0)4 90 23 96 89
t.lambert@naturex.com

Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com

 

Actus Finance contacts

Anne Catherine Bonjour
Actus Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Jérôme Fabreguettes-Leib
Investor Relations
Tel.: +33 (0)1 77 35 04 36
jfl@actus.fr

Partager sur Facebook
Article Précédent :
Naturex éligible au SRD...
Article Suivant :
Brand Licensing Central & Eastern...

Ecrire un commentaire

J'accepte la charte et que mon commentaire soit publié sur BourseReflex.com 

Les autres actualités


Retour vers 'Communiqués' »




Mots-clés : Euros   February   Euronext   Benefit   Daily   Purchase   Means   Linked   Security   Traded   Through   Italy   Spain   States   Brazil  
Sociétés citées dans cette news : Naturex   APRIL   FINANCIAL   Euronext   NYSE EURONEXT  

Si vous passez un ordre de bourse sur le CAC40 le vendredi soir à 18h, quand sera t-il éxécuté?